===== DISCHARGE NOTE =====
note_id=19128367-DS-12 | hadm_id=22801225

 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
Pancreatic tail mass
 
Major Surgical or Invasive Procedure:
___: Laparoscopic distal pancreatectomy and splenectomy.

 
History of Present Illness:
The patient is a ___ year old male who has had intermittent 
bloating over the last year.  He has not had any fevers, chills, 
constipation, diarrhea, hematochezia, hematemesis.  His weight 
has been stable over this time.  His
initial workup included a right upper quadrant ultrasound which 
was non diagnostic.  A follow up CT demonstrated a lesion in the 
tail of the pancreas.  An EUS and FNA was performed, pathology 
was consistent with low grade pancreatic neuroendocrine tumor 
positive for chromogranin and synaptophysin; negative for 
alpha-1-antitrypsin. The patient was evaluated by Dr. ___ in 
her ___ ___. After discussion of all risks, 
benefits and possible outcomes, patient was scheduled for 
elective distal pancreatectomy with splenectomy. 
 
Past Medical History:
hyperlipidemia
benign prostatic hypertrophy
obstructive sleep apnea (on intermittent CPAP)
 
Social History:
___
Family History:
father died of metastatic melanoma ___

 
Physical Exam:
At the moment of discharge 

VS: 99.4 98  131/69 18 96%RA
Alert and oriented x3
Cardiac rrr
Lungs CTA bialteral 
Abdomen soft, NT, ND. Incision CD&I. No erythema or edema . 
Drain minimal serous output (20cc)
Extremities symmetric, no edema
 
Pertinent Results:
___ 08:45AM BLOOD WBC-16.1* RBC-4.36* Hgb-12.6* Hct-37.4* 
MCV-86 MCH-28.9 MCHC-33.7 RDW-13.9 Plt ___
___ 05:10PM BLOOD WBC-20.0*# RBC-4.44* Hgb-12.7* Hct-38.4* 
MCV-87 MCH-28.6 MCHC-33.1 RDW-13.8 Plt ___
___ 08:45AM BLOOD Glucose-123* UreaN-18 Creat-0.7 Na-137 
K-4.2 Cl-104 HCO3-25 AnGap-12
___ 05:10PM BLOOD Glucose-181* UreaN-20 Creat-1.0 Na-137 
K-4.6 Cl-109* HCO3-20* AnGap-13
___ 05:10PM BLOOD Calcium-7.7* Phos-3.5 Mg-1.8

 
Brief Hospital Course:
The patient with newly diagnosed pancreatic tail mass was 
admitted to the Surgical Oncology Service for elective 
operation.  On ___, the patient underwent laparoscopic 
distal pancreatectomy with splenectomy, which went well without 
complication (reader referred to the Operative Note for 
details). After a brief, uneventful stay in the PACU, the 
patient arrived on the floor NPO with NGT, on IV fluids and 
antibiotics, with a foley catheter, and epidural for pain 
control.  The patient was hemodynamically stable.
Neuro: The patient received pain medication via epidural 
catheter with good effect and adequate pain control.  When 
tolerating oral intake, the patient was transitioned to oral 
pain medications.
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirrometry were 
encouraged throughout hospitalization.
GI/GU/FEN: Post-operatively, the patient was made NPO with IV 
fluids. Diet was advanced when appropriate, which was well 
tolerated.  Patient's intake and output were closely monitored, 
and IV fluid was adjusted when necessary.  Electrolytes were 
routinely followed, and repleted when necessary. JP amylase 
3876. Patient discharge with drain in place (appx 20cc drainage 
per day).
ID: The patient's white blood count and fever curves were 
closely watched for signs of infection.  Wound was evaluated 
daily an dno signs or symptoms of infection were noticed. 
Patient continue to have mild leukocytosis thought to be 
secondary to splenectomy.
Endocrine: The patient's blood sugar was monitored throughout 
his stay, always wnl, no need for insulun 
Hematology: The patient's complete blood count was examined 
routinely; no transfusions were required.
Prophylaxis: The patient received subcutaneous heparin and 
venodyne boots were used during this stay; was encouraged to get 
up and ambulate as early as possible.
At the time of discharge, the patient was doing well, afebrile 
with stable vital signs.  The patient was tolerating a regular 
diet, ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan.

 
Medications on Admission:
omeprazole 40', simvastatin 20', aspirin 81', vitamin C 500'

 
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H 
2. Aspirin 81 mg PO DAILY 
3. Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice 
a day Disp #*20 Capsule Refills:*0
4. Ibuprofen 600 mg PO Q8H:PRN pain 
5. Omeprazole 40 mg PO DAILY 
6. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
RX *oxycodone 5 mg ___ capsule(s) by mouth every four (4) hours 
Disp #*30 Capsule Refills:*0
7. Senna 8.6 mg PO BID 
RX *sennosides [senna] 8.6 mg 1 tab by mouth once a day Disp 
#*20 Capsule Refills:*0
8. Simvastatin 20 mg PO DAILY 
9. Bisacodyl ___AILY:PRN constipation 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___:
Pancreatic tail mass (final pathology pending)

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the surgery service at ___ for surgical 
resection of your pancreatic tail mass. You have done well in 
the post operative period and are now safe to return home to 
complete your recovery with the following instructions:
.
Please call Dr. ___ office at ___ if you have any 
questions or concerns.
.
Please resume all regular home medications , unless specifically 
advised not to take a particular medication.  Also, please take 
any new medications as prescribed.
Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids.  Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon, who will instruct you further regarding activity 
restrictions.
Avoid driving or operating heavy machinery while taking pain 
medications.
Please follow-up with your surgeon and Primary Care Provider 
(PCP) as advised.
Incision Care:
*Please call your doctor or nurse practitioner if you have 
increased pain, swelling, redness, or drainage from the incision 
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap 
and warm water.  Gently pat the area dry.
*If you have staples, they will be removed at your follow-up 
appointment.
*If you have steri-strips, they will fall off on their own.  
Please remove any remaining strips ___ days after surgery.

JP Drain Care:
*Please look at the site every day for signs of infection 
(increased redness or pain, swelling, odor, yellow or bloody 
discharge, warm to touch, fever).
*Maintain suction of the bulb.
*Note color, consistency, and amount of fluid in the drain.  
Call the doctor, ___, or ___ nurse if the amount 
increases significantly or changes in character.
*Be sure to empty the drain frequently.  Record the output, if 
instructed to do so.
*You may shower; wash the area gently with warm, soapy water.
*Keep the insertion site clean and dry otherwise.
*Avoid swimming, baths, hot tubs; do not submerge yourself in 
water.
*Make sure to keep the drain attached securely to your body to 
prevent pulling or dislocation.

 

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=19128367-DS-11 | hadm_id=29054087

 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
HOSPITAL MEDICINE EAST ATTENDING ADMISSION NOTE
time patient seen & examined: 7:50pm

CC: abdominal pain, post-EUS

 
Major Surgical or Invasive Procedure:
EUS
 
History of Present Illness:
___ man whose PMH includes BPH, hyperlipidemia, and OSA (uses 
CPAP semi-regularly), who presented with periumbilical/ low 
epigastric abdominal pain in ___, refractory to 
antacid therapy. He had an unremarkable abdominal US in ___, but on ___, CT of the abdomen showed a "hypoenhancing area 
within the tail of the pancreas concerning for neoplasm." On 
___, MRI of the abdomen showed a "lobulated hypoenhancing 
pancreatic tail mass extending into the peripancreatic fat, 
abutting the splenic artery and vein and contacting the spleen, 
highly worrisome for adenocarcinoma. There were also multiple 
hepatic hemangiomas but no liver lesion suspicious for 
metastasis." He  presented today for EUS, and he is now s/p FNA 
of the tail of the pancreas mass and lymph node. 

He reports his abdominal pain worsened after the procedure today 
but after dilaudid he feels much better. Denies associated N/V/D 
or weight loss. Extensive ROS is otherwise negative.

 
Past Medical History:
hyperlipidemia
benign prostatic hypertrophy
obstructive sleep apnea (on intermittent CPAP)
 
Social History:
___
Family History:
father died of metastatic melanoma ___

 
Physical Exam:
VS 98.9 128/84 101 16 100% RA
GEN:   NAD, well-appearing
EYES:  conjunctiva clear anicteric
ENT:   moist mucous membranes
NECK:  supple
CV:    RRR s1s2 with occasional premature beat
PULM:  CTA
GI:    normal BS, ND, soft, nontender
EXT:   feet cool, 2+ DP pulses, no edema
SKIN:  no rashes
NEURO: alert, oriented x 3, answers ? appropriately, follows
commands
PSYCH: appropriate
ACCESS: PIV  
FOLEY: none 

 
Pertinent Results:
___ 02:40PM BLOOD WBC-12.8* RBC-5.02 Hgb-14.7 Hct-42.8 
MCV-85 MCH-29.2 MCHC-34.3 RDW-14.0 Plt ___
___ 02:40PM BLOOD ___ PTT-28.8 ___
___ 02:40PM BLOOD Glucose-131* UreaN-14 Creat-0.7 Na-138 
K-3.8 Cl-105 HCO3-22 AnGap-15
___ 02:40PM BLOOD ALT-17 AST-14 AlkPhos-52 TotBili-0.5
___ 02:40PM BLOOD Lipase-24
___ 02:40PM BLOOD Calcium-8.4 Phos-2.5* Mg-1.8
___ 11:00AM BLOOD CEA-<1.0

PENDING STUDIES: CA ___, chromogranin A, serotonin, pancreatic 
polypeptide

EUS:
EUS examination revealed a 3.7 cm X 3.2 cm ill-defined mass in 
the tail of the pancreas. The mass was hypoechoic and 
heterogenous in echotexture. The borders of the mass were 
irregular and poorly defined.
Successful FNA of the mass.
The mass appeared to abut the splenic vein and artery. There was 
no caliber change. 
A lymph node was noted near the celiac axis. It measured 8 mm X 
7 mm in diameter. The lymph node was hypoechoic and 
heterogeneous in echotexture. The borders were well-defined. No 
central intra-nodal vessels were seen.
Successful FNA was performed.
Overall EUS examination concerning for tail of pancreas 
adenocarcinoma with possible encasement of splenic artery and 
vein and possible celiac lymph node.

PATHOLOGY PENDING AT THE TIME OF DISCHARGE
 
Brief Hospital Course:
Pt with recent diagnosed pancreatic mass. Underwent EUS with 
FNA. He was monitored overnight without incident. Abdominal pain 
was at baseline on the morning following procedure and he was 
tolerating regular diet. FNA results pending at the time of 
discharge. Pt will follow-up in pancreatic ___ 
clinic next week.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Simvastatin 20 mg PO DAILY 
2. Tamsulosin 0.4 mg PO HS 
3. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1. Omeprazole 40 mg PO DAILY 
2. Simvastatin 20 mg PO DAILY 
3. Tamsulosin 0.4 mg PO HS 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Pancreatic Mass

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You presented to the hospital for a biopsy of your pancreatic 
mass. You tolerated this procedure without incident. You should 
follow-up as listed below to go over your biopsy results as well 
as discuss a plan of care.

It was a pleasure taking part in your medical care.
 
Followup Instructions:
___
